Combine low-dose heparin with prostaglandin E1 and Dextran 40 to prevent and treat hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
- Author:
Qiu-ping LI
;
Wei-guo ZHU
;
Xiao-juan YIN
;
Zhi-chun FENG
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Alprostadil;
pharmacology;
Anticoagulants;
pharmacology;
Child;
Child, Preschool;
Dextrans;
pharmacology;
Female;
Fibrinolytic Agents;
pharmacology;
Hematopoietic Stem Cell Transplantation;
adverse effects;
Heparin;
pharmacology;
Hepatic Veno-Occlusive Disease;
etiology;
prevention & control;
therapy;
Humans;
Infant;
Male;
Middle Aged;
Platelet Aggregation Inhibitors;
pharmacology;
Treatment Outcome
- From:
Chinese Journal of Pediatrics
2004;42(7):537-538
- CountryChina
- Language:Chinese
